Header Logo

Connection

Robert Goldberg to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications Robert Goldberg has written about Tumor Necrosis Factor-alpha.
Connection Strength

0.095
  1. Ayabe R, Rootman DB, Hwang CJ, Ben-Artzi A, Goldberg R. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2014 Sep-Oct; 30(5):415-9.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.